News Releases
Mar 13 2018
Avid Bioservices to Participate at Upcoming CDMO Industry Conferences
Mar 12 2018
Avid Bioservices Reports Financial Results for Third Quarter of Fiscal Year 2018 and Recent Developments
Mar 7 2018
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
Mar 6 2018
Avid Bioservices to Present at the 30th Annual ROTH Conference
Mar 5 2018
Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2018 After Market Close on March 12, 2018
Mar 1 2018
Avid Bioservices Selected by Acumen Pharmaceuticals to Lead Process Development and Clinical Manufacture of Novel Alzheimer's Disease Candidate
Feb 26 2018
Avid Bioservices Announces Resignation of Chief Financial Officer
Feb 21 2018
Avid Bioservices Selected as Commercial Manufacturer for Critical Enzyme Replacement Therapy by Enzyvant, a Subsidiary of Roivant Sciences
Feb 20 2018
Avid Bioservices Announces Closing of Public Offering of Common Stock
Feb 15 2018
Avid Bioservices Announces Pricing of Public Offering of Common Stock